Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s share price gapped up before the market opened on Friday. The stock had previously closed at $149.71, but opened at $158.90. Merck KGaA shares last traded at $160.00, with a volume of 109 shares trading hands.
Merck KGaA Stock Up 6.6%
The business has a 50 day moving average of $161.35 and a two-hundred day moving average of $151.18. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock has a market capitalization of $20.63 billion, a PE ratio of 24.37 and a beta of 0.96.
Institutional Investors Weigh In On Merck KGaA
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. MASTERINVEST Kapitalanlage GmbH acquired a new position in shares of Merck KGaA during the second quarter valued at about $4,896,000. Puzo Michael J purchased a new position in shares of Merck KGaA in the second quarter worth $2,230,000. Somerville Kurt F acquired a new stake in shares of Merck KGaA during the second quarter worth $1,997,000. Pinnacle Holdings LLC purchased a new stake in shares of Merck KGaA during the second quarter valued at $1,487,000. Finally, North Star Asset Management Inc. acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $1,411,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.
About Merck KGaA
Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. Merck KGaA is separate from the U.S.-based Merck & Co, Inc, although the two companies share historical roots.
The company operates through three business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, chemicals and bioprocessing technologies used by pharmaceutical, biotechnology and academic customers.
Further Reading
- Five stocks we like better than Merck KGaA
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
- Target’s Holiday Blitz: Slashing Prices to Capture Market Share
- NIO Inc.’s Geely Deal Is Really a Bet on Battery-Swap Network Utilization
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
